CRP and cardiovascular disorder: Certain biomarkers, such as high-sensitivity C-reactive protein (hs-CRP) and Hemoglobin A1c (HbA1c), also called glycated hemoglobin, have demonstrated their ability to forecast cardiovascular diseases (CVDs) in people with DM [7].